Tailored treatments: Promising designer drug provides new insight into cancer biology
13th Nov 2006, 19:11 GMT
Scientists are making progress toward unraveling the molecular mysteries that underlie cancer progression and treatment resistance. Two studies in the November 2006 issue of the journal Cancer Cell, published by Cell Press, provide mechanistic details that may explain why the small-molecule chemical ABT-737 is emerging as a unique and effective anticancer agent.
Tailored treatments: Promising designer drug provides new insight into cancer biology related news:
- NICE consults on advice on two treatments for NSCLC — OnMedica Latest News
- Designer drug to blame for disintegrating euro notes — News
- Recurrent breast cancer: Drug shows promise — The Cancer Blog
- Dendreon completes FDA filing for prostate-cancer drug — The Seattle Times: Horse racing
- Exercise, aspirin consumption and childbirth may alter cancer risk — EurekAlert! - Biology
- Cancer drug guidance concern — BBC News | Health | UK Edition
- Dismay over cancer drug guidance — BBC News | Latest Published Stories | UK Edition
- NICE rejects use of cancer drug Tarceva — Pharmaceutical Business Review Latest News
- Cancer drug guidance dismay — BBC News | UK News | England | World Edition
- NICE refuses to fund £20,000 cancer drug available in Scotland — the Mail online | Home
Latest news from EurekAlert! - Biology:
- Climate change creates dramatic decline in red-winged black bird population
- Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry
- University of Iowa scientists explore function of 'junk DNA'
- Scientists urge collaborative action to address effects of global environmental change
- New insight about the source of anxiety in Rett syndrome
- Sticky proteins provide new insight into drug action
- New study finds on/off switch for septic shock
- Transforming knowledge into economic benefits -- EPSRC's First Knowledge Transfer Challenge Awards
- Wielding the subtle weapons of a fungus
- Taking 'chips' to the next level of gene hunting